THE FUTURE OF BLOOD FLOW SUPPLEMENTATION

Black Ginger is so much more than a simple N.O. booster, going beyond just potential blood flow benefits.

Clinical studies have suggested that Black Ginger may improve overall energy production which would be beneficial to muscle endurance and physical performance. As well as may increase handgrip strength*.

Research also showed that Black Ginger activates AMPK (AMP-activated protein kinase) as well as activates BAT (brown adipose tissues) which is the ‘good' type of fat mass which is thermogenic, abundant in mitochondria (the powerhouses of the cells) and beneficial for energy expenditure*.

The research suggests positive effects in terms of improving body composition from using Black Ginger.*

A NATURAL SOURCE OF PDE5 INHIBITORS

More importantly, clinical studies have shown that Black Ginger contains natural PDE5 inhibitors which inhibit the enzyme that breaks down N.O.*

PDE5 inhibition may increase the availability of N.O. and prolong vasodilation, which is very beneficial for blood flow.*

The most common pharmaceutical PDE5 inhibitors on the market inhibit this enzyme very strongly and may come with plenty of side effects such as back pain, vision disturbances, dizziness, flushing, dyspepsia, nasal congestion, and rhinitis.*

Black Ginger, inhibit this enzyme to a milder degree with no known side effects.*

BOOST BLOOD FLOW BY TRUSTING CENTURIES OF TRADITIONAL USE BY MEN

Researches suggest Black Ginger ​may primarily work in two ways; by improving vasodilation and blood circulation (PDE5 inhibition)*, as well as by boosting the levels of feel-good neurotransmitters and their sensitivity*.

Neurotransmitters play an important role in the body.

Clinical studies have suggested that Black Ginger may work as a mild anti-depressant* because the way it modulates the amounts of neurotransmitters by stimulating dopaminergic function in the hypothalamus.*

Keep in mind that the effects of Black Ginger are ​NOT comparable in strength to other common pharmaceutical PDE5 inhibitors on the market although they may work in similar ways.